Orion stock: Orion upgrades 2026 outlook. Report due October 28, 2026

Published on 10/24/2026 at 01:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Orion lifts 2026 net sales guidance to EUR 2.07 billion-2.14 billion. Orion stock faces its October 28 report and EUR 730 million-790 million operating outlook.

Guidance and valuation markers

Orion upgraded its 2026 outlook on October 20, 2026.
Net sales guidance is EUR 2.07 billion to EUR 2.14 billion for fiscal year 2026.
Market capitalization stood at EUR 13.0 billion on October 23, 2026.

3D-Architekturrender eines Bürogebäudes mit Glasfassade, Orion Oyj FI0009014377 — Architektur-Render zeigt futuristisches Firmengebäude von Orion Oyj, ISIN FI0009014377, mit Glasfassade und Grünflächen, Illustration mit AI erstellt.

Orion Corporation (ISIN FI0009014377) upgraded its 2026 outlook on October 20, 2026, lifting its net sales estimate to EUR 2,070 million-2,140 million and its operating profit estimate to EUR 730 million-790 million. The change came as royalty income grew faster than expected during the first nine months of 2026, according to Globenewswire. Orion stock now approaches the company's January-September report.

Guidance moves higher

The revised net sales range starts EUR 70 million above the previous lower bound of EUR 2,000 million and reaches EUR 40 million above the prior upper bound of EUR 2,100 million. The operating profit range also shifted upward, from EUR 650 million-750 million to EUR 730 million-790 million for fiscal year 2026.

For investors, the key change is the source of the upgrade. Orion said royalty income increased faster than expected during the first nine months of 2026 and that this development was expected to continue through the remainder of the year. The guidance therefore puts royalty performance ahead of the next reported quarterly figures.

Three dated company steps

On October 5, 2026, Orion reported that the first patient had been dosed in its ODM-216 Phase 1/2 clinical trial, as listed on the company's Orion investor page. On October 7, 2026, the company disclosed the conversion of 125,000 A shares into B shares on the same page. On October 20, 2026, Orion raised its 2026 net sales guidance to EUR 2,070 million-2,140 million and operating profit guidance to EUR 730 million-790 million, according to Globenewswire.

When is the next report?

Orion will publish its January-September 2026 interim report on October 28, 2026, according to the October 20 release. That report will show how the first nine months developed against the higher full-year ranges and whether royalty income continued to provide the main earnings support.

Valuation and trading context

Orion's market capitalization was EUR 13.0 billion on October 23, 2026. The 52-week range was EUR 54.15-EUR 92.50 on the same date, placing the upper end within EUR 0.02 of the latest quoted range high. The company is listed as ORNBV.HE on Nasdaq Helsinki and operates in pharmaceuticals.

The next confirmed company date is October 28, 2026, when the interim report for January-September 2026 is due. The report matters because the upgraded outlook depends on royalty income continuing to improve during the final part of fiscal year 2026.

What comes next for Orion?

The October 20 guidance increase gives the upcoming report a higher benchmark. Orion must now show progress toward EUR 2,070 million-2,140 million in net sales and EUR 730 million-790 million in operating profit for fiscal year 2026.

The further course of trading is shown by the continuously updated real-time quote of Orion stock.